| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Spero Therapeutics, Inc. (SPRO) has 10 insiders with recent SEC Form 4 filings, including 4 buys and 17 sells. SPRO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 986.9K | $2.42M | -25,240 | |
| COO | 742.5K | $1.82M | - | |
| Dir | 703.3K | $1.72M | - | |
| Dir | 91.5K | $224.1K | - | |
| Dir | 75.0K | $183.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2020 | Mahadevia Ankit58 | CEO And President | Sale+OE | 774 | $14.25 | $11,029.73 | -1.2% | |
| Jul 9, 2020 | Mahadevia Ankit58 | CEO And President | Sale+OE | 3,047 | $14.29 | $43,551.59 | -2.3% | |
| Jun 25, 2020 | Mahadevia Ankit58 | CEO And President | Sale+OE | 17,180 | $14.30 | $245,698.73 | -6.1% | |
| Jul 17, 2018 | Glaxosmithkline Plc | 10% Owner | Buy | 80,000 | $12.50 | $1,000,000.00 | +4.3% | |
| Jul 6, 2018 | Mahadevia Ankit58 | See Remarks | Sale+OE | 4,676 | $17.63 | $82,436.73 | -0.9% | |
| Jul 5, 2018 | Larkin Cristina | Chief Operating Officer | Sale+OE | 4,000 | $17.50 | $70,000.00 | -72.7% | |
| Jul 5, 2018 | Sendek Joel | Chief Financial Officer | Sale+OE | 2,000 | $17.50 | $35,000.00 | -11.6% | |
| Nov 6, 2017 | Formela Jean Francois70 | Director | Buy | 428,571 | $14.00 | $5,999,994.00 | +21.6% | |
| Nov 6, 2017 | Goyal Vikas | Director | Buy | 428,571 | $14.00 | $5,999,994.00 | +30.1% | |
| Nov 6, 2017 | Sendek Joel | Chief Financial Officer | Buy | 5,000 | $14.00 | $70,000.00 | +49.1% |